paxilline has been researched along with Carcinoma, Adenosquamous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Chen, S; Jiang, S; Li, D; Li, J; Liang, L; Liu, Z; Yang, Z; Yuan, Y; Zou, Q | 1 |
1 other study(ies) available for paxilline and Carcinoma, Adenosquamous
| Article | Year |
|---|---|
Paxillin and carbonic anhydrase IX are prognostic markers in gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers, Tumor; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Gallbladder Neoplasms; Humans; Male; Middle Aged; Paxillin; Prognosis | 2014 |